Quantification of apixaban's therapeutic utility in prevention of venous thromboembolism: selection of phase III trial dose - Leil, T A; Feng, Y; Zhang, L; Paccaly, A; Mohan, P; Pfister, M (Clin Pharmacol Ther, 2010)